AJAgnès Jacquin-Piques

Agnès Jacquin-Piques

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Agnès Jacquin-Piques has a total of 33 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • The pleasantness of foods

    by Agnès Jacquin-Piques


  • Top Cited Papers
    Open Access

    Exploring the Role of Apigenin in Neuroinflammation: Insights and Implications

    by Karine Charrière, Vincent Schneider, Manon Perrignon-Sommet, Gérard Lizard, Alexandre Benani, Agnès Jacquin-Piques, Anne Vejux

    Neuroinflammation, a hallmark of various central nervous system disorders, is often associated with oxidative stress and neuronal or oligodendrocyte cell death. It is therefore very interesting to target neuroinflammation pharmacologically. One therapeutic option is the use of nutraceuticals, particularly apigenin. Apigenin is present in plants: vegetables (parsley, celery, onions), fruits (oranges), herbs (chamomile, thyme, oregano, basil), and some beverages (tea, beer, and wine). This review explores the potential of apigenin as an anti-inflammatory agent across diverse neurological conditions (multiple sclerosis, Parkinson’s disease, Alzheimer’s disease), cancer, cardiovascular diseases, cognitive and memory disorders, and toxicity related to trace metals and other chemicals. Drawing upon major studies, we summarize apigenin’s multifaceted effects and underlying mechanisms in neuroinflammation. Our review underscores apigenin’s therapeutic promise and calls for further investigation into its clinical applications.


  • Open Access

    Prolonged latency of the Gustatory Evoked Potentials for sucrose solution in subjects living with obesity compared with normal-weight subjects

    by Agnès Jacquin-Piques, Thomas Mouillot, Marie-Claude Brindisi, Cyril Gauthier, Sophie Barthet, Clémence Quere, Djihed Litime, Manon Perrignon-Sommet, Sylvie Grall, Fabienne Lienard, et al.

    Objectives A difference in cortical treatment of taste information could alter food intake promoting the development of obesity. The main purpose was to compare, in subjects living with obesity (OB) and normal-weight subjects (NW), the characteristics of gustatory evoked potentials (GEP) for sucrose solution (10 g.100 mL− 1) before and after a standard lunch. The secondary objective was to evaluate the correlations between GEP and the plasmatic levels of acylated ghrelin, leptin, insulin and serotonin.Methods Each subject had 2 randomized sessions spaced by an interval of 2 days. During one session, subjects were fasting and during the other, subjects took a lunch low in sugar. In each session, subjects had a blood test before a first GEP recording followed by a second GEP recording either after a lunch (feeding session) or no lunch (fasting session).Results Twenty-eight OB (BMI: 38.6 ± 9.0 kg.m− 2) were matched to 22 NW (BMI: 22.3 ± 2.2 kg.m− 2). GEP latencies were prolonged in OB regardless the sessions and the time before and after lunch, compared with NW (in Cz at the morning: 170 ± 33 ms vs 138 ± 25 ms respectively; p < 0.001). The increase in latency observed in NW after lunch was not observed in OB. Negative or positive correlations were noted between GEP latencies and ghrelin, leptin, insulin plasmatic levels (P1Cz, r = − 0.38, r = 0.33, r = 0.37 respectively, p < 0.0001).Conclusions This study highlights a slower activation in the taste cortex in OB compared with NW.

  • Open Access

    Differential Cerebral Gustatory Responses to Sucrose, Aspartame, and Stevia Using Gustatory Evoked Potentials in Humans

    by Thomas Mouillot, Anaïs Parise, Camille Greco, Sophie Barthet, Marie-Claude Brindisi, Luc Penicaud, Corinne Leloup, Laurent Brondel, Agnès Jacquin-Piques

    Aspartame and Stevia are widely substituted for sugar. Little is known about cerebral activation in response to low-caloric sweeteners in comparison with high-caloric sugar, whereas these molecules lead to different metabolic effects. We aimed to compare gustatory evoked potentials (GEPs) obtained in response to sucrose solution in young, healthy subjects, with GEPs obtained in response to aspartame and Stevia. Twenty healthy volunteers were randomly stimulated with three solutions of similar intensities of sweetness: Sucrose 10 g/100 mL of water, aspartame 0.05 g/100 mL, and Stevia 0.03 g/100 mL. GEPs were recorded with EEG (Electroencephalogram) electrodes. Hedonic values of each solution were evaluated using the visual analog scale (VAS). The main result was that P1 latencies of GEPs were significantly shorter when subjects were stimulated by the sucrose solution than when they were stimulated by either the aspartame or the Stevia one. P1 latencies were also significantly shorter when subjects were stimulated by the aspartame solution than the Stevia one. No significant correlation was noted between GEP parameters and hedonic values marked by VAS. Although sucrose, aspartame, and Stevia lead to the same taste perception, cerebral activation by these three sweet solutions are different according to GEPs recording. Besides differences of taste receptors and cerebral areas activated by these substances, neural plasticity, and change in synaptic connections related to sweet innate preference and sweet conditioning, could be the best hypothesis to explain the differences in cerebral gustatory processing after sucrose and sweeteners activation.


  • Open Access

    Cerebral gustatory activation in response to free fatty acids using gustatory evoked potentials in humans

    by Thomas Mouillot, Emilie Szleper, Gaspard Vagne, Sophie Barthet, Djihed Litime, Marie-Claude Brindisi, Corinne Leloup, Luc Penicaud, Sophie Nicklaus, Laurent Brondel, et al.


  • Microangiopathie cérébrale et troubles cognitifs

    by Agnès Jacquin-Piques

    Zusammenfassung. Zerebrale Mikroangiopathien umfassen eine Gruppe neuropathologischer Prozesse, die die kleinen Perforationsarterien, Arteriolen und Kapillaren beeinflussen. Neuroimaging-Merkmale der Einengung der kleinen Koronararterienäste (Small Vessel Disease) sind ischämische und hämorrhagische Marker: jüngster kleiner subkortikaler Infarkt, Lakune vermuteten vaskulären Ursprungs, Hyperintensität der weissen Masse, perivaskuläre Räume, zerebrale Mikroblutungen, Hirnatrophie, kortikale oberflächliche Siderose und akute subarachnoidale Blutungen. Diese Läsionen gelten als der Hauptrisikofaktor der vaskulären kognitiven Störungen. Die zerebrale Mikroangiopathie wird typischerweise in zwei Hauptformen kategorisiert: die nicht-amyloide Angiopathie, die auch als «hypertensive Arteriopathie» bezeichnet wird, die oft mit fortgeschrittenem Alter und vaskulären Risikofaktoren und der zerebralen Amyloidangiopathie zusammenhängt. Die zerebrale Amyloidangiopathie ist klinisch charakterisiert durch kognitive Beeinträchtigungen, intrazerebrale Blutungen und durch transiente Episoden fokal-neurologischer Defizite aufgrund von Subarachnoidalblutungen.